Differences in the magnitude of wave reflection account for differential effects of amlodipine- versus atenolol-based regimens on central blood pressure: An anglo-scandinavian cardiac outcome trial substudy

Hypertension

Volumn 54, Issue 4, 2009, Pages 724-730

  Manisty, Charlotte H ^a   Zambanini, Andrew ^a   Parker, Kim H ^a,b   Davies, Justin E ^a   Francis, Darrel P ^a   Mayet, Jamil ^a   McG Thom, Simon A ^a   Hughes, Alun D ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Blood pressure; Flow; Hypertension; Pressure; Wave intensity; Wave reflection

Indexed keywords

AMLODIPINE; ATENOLOL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AORTA PRESSURE; ARTERY BLOOD FLOW; ARTICLE; BLOOD PRESSURE MEASUREMENT; BODY MASS; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG EFFECT; FEMALE; FLOW RATE; HEART LEFT VENTRICLE MASS; HEART STROKE VOLUME; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERIES; FEMALE; HEART VENTRICLES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULSATILE FLOW; SYSTOLE; TREATMENT OUTCOME;

EID: 70349680426     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.125740     Document Type: Article

References (41)

1. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks: US population data. Arch Int Med. 1993;153: 598-615.
2. Nichols WW, O'Rourke MF. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. V ed. London, United Kingdom: Hodder Arnold; 2005:166-267.
3. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension. 2001;38:434-438.
4. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Berent R, Eber B. Arterial stiffness, wave reflections, and the risk of coronary artery disease. Circulation. 2004;109:184-189.
5. Weber T, Auer J, O'Rourke MF, Kvas E, Lassnig E, Lamm G, Stark N, Rammer M, Eber B. Increased arterial wave reflections predict severe cardiovascular events in patients undergoing percutaneous coronary interventions. Eur Heart J. 2005;26:2657-2663.
6. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, Umans JG, Howard BV. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: The Strong Heart Study. Hypertension. 2007;50:197-203.
7. Williams B, Lacy PS, Thom SM, Cruickshank K, Stanton A, Collier D, Hughes AD, Thurston H, O'Rourke M. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study. Circulation. 2006;113:1213-1225.
8. Dart AM, Cameron JD, Gatzka CD, Willson K, Liang YL, Berry KL, Wing LMH, Reid CM, Ryan P, Beilin LJ, Jennings GLR, Johnston CI, McNeil JJ, MacDonald GJ, Morgan TO, West MJ, Kingwell BA. Similar effects of treatment on central and brachial blood pressures in older hypertensive subjects in the Second Australian National Blood Pressure Trial. Hypertension. 2007;49:1242-1247.
9. Lehman ED. Where is the evidence that radial artery tonometry can be used to accurately and noninvasively predict central aortic blood pressure in patients with diabetes? Diabetes Care. 2000;23:869-871.
10. Williams B. Pulse wave analysis and hypertension: Evangelism versus scepticism. J Hypertens. 2004;22:447-449.
11. Dart AM, Gatzka CD, Kingwell B. Letter by Dart et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study." Circulation. 2006;114:e537.
12. Cameron JD, Meredith IT, Hope SA. Letter by Cameron et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study." Circulation. 2006;114:e538.
13. Hope SA, Meredith IT, Tay D, Cameron JD. 'Generalizability' of a radial-aortic transfer function for the derivation of central aortic waveform parameters. J Hypertens. 2007;25:1812-1820.
14. Chen CH, Ting CT, Nussbacher A, Nevo E, Kass DA, Pak P, Wang SP, Chang MS, Yin FC. Validation of carotid artery tonometry as a means of estimating augmentation index of ascending aortic pressure. Hypertension. 1996;27:168-175.
15. Cameron JD, McGrath BP, Dart AM. Use of radial artery applanation tonometry and a generalized transfer function to determine aortic pressure augmentation in subjects with treated hypertension. J Am Coll Cardiol. 1998;32:1214-1220.
16. Segers P, Rietzschel E, Heireman S, De BM, Gillebert T, Verdonck P, Van BL. Carotid tonometry versus synthesized aorta pressure waves for the estimation of central systolic blood pressure and augmentation index. Am J Hypertens. 2005;18:1168-1173.
17. Dahlof B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): A multicentre randomised controlled trial. Lancet. 2005;366:895-906.
18. O'Brien E, Mee F, Atkins N, Thomas M. Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: The Omron HEM-705CP, Phillips HP5332, and Nissei DS. Blood Press Monit. 1996;1:55-61.
19. London GE, Guerin AP, Marchais SJ, Pannier B, Safar ME, Day M, Metivier F. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996;50:600-608.
20. Kelly R, Hayward C, Avolio A, O'Rourke M. Noninvasive determination of age-related changes in the human arterial pulse. Circulation. 1989;80: 1652-1659.
21. Zambanini A, Cunningham SL, Parker KH, Khir AW, McG Thom SA, Hughes AD. Wave-energy patterns in carotid, brachial, and radial arteries: A noninvasive approach using wave-intensity analysis. Am J Physiol Heart Circ Physiol. 2005;289:H270-H276.
22. Khir AW, O'Brien A, Gibbs JS, Parker KH. Determination of wave speed and wave separation in the arteries. J Biomech. 2001;34:1145-1155.
23. Zambanini A, Khir AW, Byrd SM, Parker KH, Thom SAM, Hughes AD. Wave intensity analysis: A novel non-invasive method for determining arterial wave transmission. Comput Cardiol. 2002;29:717-720.
24. Davies JE, Whinnett ZI, Francis DP, Willson K, Foale RA, Malik IS, Hughes AD, Parker KH, Mayet J. Use of simultaneous pressure and velocity measurements to estimate arterial wave speed at a single site in humans. Am J Physiol Heart Circ Physiol. 2006;290:H878-H885.
25. Sharp A, Tapp R, Francis DP, McG Thom SA, Hughes AD, Stanton AV, Zambanini A, Chaturvedi N, Byrd S, Poulter NR, Sever PS, Mayet J. Ethnicity and left ventricular diastolic function in hypertension an ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial) substudy. J Am Coll Cardiol. 2008;52:1015-1021.
26. Parker KH, Jones CJ. Forward and backward running waves in the arteries: Analysis using the method of characteristics. J Biomech Eng. 1990;112:322-326.
27. Bleasdale RA, Mumford CE, Campbell RI, Fraser AG, Jones CJ, Frenneaux MP. Wave intensity analysis from the common carotid artery: A new noninvasive index of cerebral vasomotor tone. Heart Vessels. 2003;18:202-206.
28. Davies JE, Whinnett ZI, Francis DP, Manisty CH, guado-Sierra J, Willson K, Foale RA, Malik IS, Hughes AD, Parker KH, Mayet J. Evidence of a dominant backward-propagating "suction" wave responsible for diastolic coronary filling in humans, attenuated in left ventricular hypertrophy. Circulation. 2006;113:1768-1778.
29. Ting CT, Brin KP, Lin SJ, Wang SP, Chang MS, Chiang BN, Yin FC. Arterial hemodynamics in human hypertension. J Clin Invest. 1986;78: 1462-1471.
30. Segers P, Verdonck P. Role of tapering in aortic wave reflection: Hydraulic and mathematical model study. J Biomech. 2000;33:299-306.
31. Levy D, Garrsion RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Study. N Engl J Med. 1990;322:1561-1566. (Pubitemid 20176696)
32. Nichols WW, Singh BM. Augmentation index as a measure of peripheral vascular disease state. Curr Opin Cardiol. 2002;17:543-551.
33. Dhakam Z, McEniery CM, Yasmin, Cockcroft JR, Brown MJ, Wilkinson IB. Atenolol and eprosartan: Differential effects on central blood pressure and aortic pulse wave velocity. Am J Hypertens. 2006;19:214-219.
34. London GM, Asmar RG, O'Rourke MF, Safar ME. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/indapamide in hypertensive subjects: Comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99.
35. Nichols WW, Avolio AP, Kelly R. Effects of age and hypertension on wave travel and reflections. In: O'Rourke MF, Safar M, Dzau V, eds. Arterial Vasodilatation: Mechanisms and Therapy. London, United Kingdom: Edward Arnold; 1993:23-40.
36. Chen CH, Ting CT, Lin SJ, Hsu TL, Yin FC, Siu CO, Chou P, Wang SP, Chang MS. Different effects of fosinopril and atenolol on wave reflections in hypertensive patients. Hypertension. 1995;25:1034-1041.
37. Ting CT, Chen JW, Chang MS, Yin FC. Arterial hemodynamics in human hypertension: Effects of the calcium channel antagonist nifedipine. Hypertension. 1995;25:1326-1332.
38. Jones CJ, Sugawara M, Kondoh Y, Uchida K, Parker KH. Compression and expansion wavefront travel in canine ascending aortic flow: wave intensity analysis. Heart Vessels. 2002;16:91-98.
39. Conway FJ, Fitzgerald JD, McAinsh J, Rowlands DJ, Simpson WT. Human pharmacokinetic and pharmacodynamic studies on atenolol (ICI 66,082), a new cardioselective-adrenoceptor blocking drug. Br J Clin Pharmacol. 1976;3:267-272.
40. Kukin ML, Mannino MM, Freudenberger RS, Kalman J, Buchholz- Varley C, Ocampo O. Hemodynamic comparison of twice daily metoprolol tartrate with once daily metoprolol succinate in congestive heart failure. J Am Coll Cardiol. 2000;35:45-50.
41. Nieminen T, Kahonen M, Koobi T. Letter by Nieminen et al regarding article, "Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: Principal results of the Conduit Artery Function Evaluation (CAFE) Study." Circulation. 2006 10;114:e536.